Menu Search
Equities

Sedana Medical AB (publ)

7D2A:DEU

Sedana Medical AB (publ)

Actions
  • Price (EUR)1.11
  • Today's Change-0.024 / -2.12%
  • Shares traded0.00
  • 1 Year change-29.51%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Sedana Medical AB (publ) grew revenues 25.23% from 122.87m to 153.87m while net income improved from a loss of 73.51m to a smaller loss of 59.61m.
Gross margin70.60%
Net profit margin-32.87%
Operating margin-31.46%
Return on assets-5.58%
Return on equity-5.85%
Return on investment-5.84%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Sedana Medical AB (publ) fell by 376.56m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 38.06m for operations while cash used for investing totalled 321.96m.
Cash flow per share-0.3527
Price/Cash flow per share--
Book value per share9.56
Tangible book value per share2.73
More ▼

Balance sheet in SEKView more

Sedana Medical AB (publ) has little financial risk as the capital structure does not rely on leverage.
Current ratio6.91
Quick ratio6.02
Total debt/total equity0.0076
Total debt/total capital0.0076
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.